2seventy bio Inc. When-Issued (TSVTV) Key Ratios
$25.23
As on 06-Jan-2022EDT
Market cap
$621 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
19.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | 4.46 | 460.15 | -- | -- |
| EBIT | -- | -- | -- | -- | -- |
| Net Profit | -- | 16.75 | 62.53 | -- | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-20 | Dec-19 | Dec-18 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | -203.03 | -- | -- |
| Return on Capital
| -- | -- | -203.03 | -- | -- |
| Return on Assets
| -- | -- | -38.28 | -- | -- |
| Debt to Equity (x)
| -- | -- | -- | -- | -- |
Profitability
ROCE
-203.03
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
-203.03
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-203.03
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
-203.03
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-38.28
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
-38.28
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-48.41
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
-48.41
|
-723.75
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
4.60
--
Year on year growth in net sales
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
4.60
|
-0.19
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
62.53
--
Year on year growth in profit after tax
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
62.53
|
-60.50
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Current Ratio
0.33
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
0.33
|
0.20
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
4.31
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
4.31
|
16.76
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.79
--
Sales / Average Total Assets
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
0.79
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
13.33
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
13.33
|
61.23
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
932.11
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
932.11
|
2,500.70
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|